TajMedico is a science-driven pharmaceutical organization committed to delivering safe, effective, and high-quality medicines through a robust Quality Control (QC) system. The company ensures that every product released to the market meets strict national and international regulatory standards, including WHO-GMP, IP, USP, BP, and ICH guidelines.
At the heart of TajMedico’s manufacturing excellence lies its well-equipped Quality Control laboratory, designed to perform comprehensive testing of raw materials, in-process samples, and finished products. The QC system ensures complete assurance of purity, potency, safety, and consistency across all pharmaceutical formulations.
🔬 Advanced QC Laboratory Infrastructure
TajMedico’s QC lab is equipped with modern analytical instruments such as:
- High-Performance Liquid Chromatography (HPLC)
- Gas Chromatography (GC)
- UV-Visible Spectrophotometer
- FTIR Spectroscopy
- Dissolution & Disintegration Test Apparatus
- Hardness, Friability & Thickness Testers
- Microbiological Testing Facilities
These systems ensure precise, reliable, and reproducible testing results for all dosage forms.
💊 Quality Control for OSD & External Preparations
Oral Solid Dosage (OSD)
Includes tablets, capsules, granules, and pellets.
Key QC Tests:
- Assay of active ingredients
- Content uniformity
- Dissolution profiling
- Hardness & friability
- Moisture analysis
- Stability testing
External Preparations
Includes creams, ointments, gels, lotions, and liquids.
Key QC Tests:
- pH and viscosity analysis
- Homogeneity & spreadability
- Microbial limit testing
- Preservative efficacy testing
- Stability and compatibility studies
⚙️ In-Process Quality Control (IPQC)
TajMedico ensures real-time monitoring during production to maintain consistency and prevent deviations. Key parameters include:
- Blend uniformity
- Granulation quality
- Tablet weight variation
- Coating uniformity
- Filling accuracy for topicals
This proactive system ensures zero-defect manufacturing approach.
📊 Stability Studies & Regulatory Compliance
All products undergo accelerated and long-term stability studies as per ICH guidelines to determine shelf life, storage conditions, and product performance over time.
Every batch is released only after:
- Full analytical testing
- QA approval
- Compliance verification
- Documentation review (CoA, BMR, BPR)
👩🔬 Skilled Quality Team
TajMedico’s QC division is managed by highly trained professionals including:
- Analytical Chemists
- Microbiologists
- Quality Assurance Experts
- Validation Specialists
Continuous training ensures alignment with evolving global regulatory standards.
🌍 Commitment to Global Quality Standards
TajMedico operates under a Quality by Design (QbD) approach, ensuring every product is:
✔ Safe for patients
✔ Consistent in performance
✔ Compliant with global regulations
✔ Manufactured with precision and control
Contact Details – TajMedico
Corporate Office:
TajMedico India Limited
Mumbai, Maharashtra, India
Manufacturing Facility:
Sarigam GIDC Industrial Area
Gujarat, India
Business Enquiry Email:
📧 info@tajpharma.com
📧 tajgroup@tajpharma.com
Phone:
📞 +91-7400009975/76 (Sales & Business Support)




![[Liver cancer] deaths climb by around 50% in the last decade {Taj Pharmaceuticals Survey}](https://tajmedico.com/wp-content/uploads/cache/images/Liver-cancer-deaths-climb-by-around-50-in-the-last-decade-Taj-Pharmaceuticals-Survey-2-scaled/Liver-cancer-deaths-climb-by-around-50-in-the-last-decade-Taj-Pharmaceuticals-Survey-2-scaled-860068172.jpg)
![Blood Tests: Using Blood to detect Cancer Early {Cancer is word; not a sentence} [Taj Pharmaceuticals Mumbai]](https://tajmedico.com/wp-content/uploads/cache/images/Blood-Tests-Using-Blood-to-detect-Cancer-Early-Cancer-is-word-not-a-sentence-Taj-Pharmaceuticals-Mumbai/Blood-Tests-Using-Blood-to-detect-Cancer-Early-Cancer-is-word-not-a-sentence-Taj-Pharmaceuticals-Mumbai-2746981357.jpg)


![WHO releases guideline on digital health interventions {Taj Pharmaceuticals} [Patient Care]](https://tajmedico.com/wp-content/uploads/cache/images/WHO-releases-guideline-on-digital-health-interventions-Taj-Pharmaceuticals-Patient-Care-by-Taj-Pharma-Group-Taj-Medico/WHO-releases-guideline-on-digital-health-interventions-Taj-Pharmaceuticals-Patient-Care-by-Taj-Pharma-Group-Taj-Medico-1592706783.jpg)